Appendix Table 1. Distribution of treatment across sub-samples defining a gradient of need for treatment across service sectors 1

Similar documents
Appendix table 1. Gender differences in lifetime prevalence, inter-quartile range. and ageof-onset of DSM-IV/CIDI bipolar disorder (BPD)

Use of Mind Body Approaches among US Children Age 4-17 Years: Child Characteristics and Reported Reasons and Benefits for Use

Complementary and Alternative Medicine

conventional and unconventional Medical Practice

medicine (CAM): group of practices used Alternative medicine: group of practices used as an Integrative medicine: use of conventional medicine in

What does complementary medicine and alternative medicine mean?

Dietary supplement use in cancer patients: is there a link to psychosocial wellbeing?

Chapter 11. Major Characteristics of CAM. Research. CAM Healing Methods. Complementary and Alternative Medicine (CAM) CAM Healing Methods (continued)

CONVENTIONAL AND COMPLEMENTARY MEDICINE: SKILLS FOR THE HEALTH CARE CONSUMER. Chapter 20

BRONX COMMUNITY COLLEGE LIBRARY SUGGESTED FOR PSY 31 ABNORMAL PSYCHOLOGY

Complementary Therapies

??? Why should you care? 9/26/2016. Lee Anne Hellesto, NP Discover Health, LLC

Complementary/Integrative Approaches to Treating PTSD & TBI

SUMMARY INSTRUCTOR RESOURCES

Use of complementary and alternative medicine among United States adults: the influences of personality, coping strategies, and social support

Complementary and Alternative Therapies: Myths, Realities and Opportunities. Learning Objectives. CAM Use in Lymphoma Survivors

Abusing drugs can reduce the effectiveness of your treatment, prolong your illness and increase the risk of side effects.

NIS Section D Health Proxy Child

Contemporary Psychiatric-Mental Health Nursing Third Edition. Nursing Role in CAM. Nursing Role in CAM (cont'd) 8/22/2016

THE UNMET NEED CHRONIC PAIN AND CHRONIC ILLNESS DEL WORLEY, MC, LPC, LISAC SOUTHWEST INSTITUTE FOR GROUP AND FAMILY THERAPY

Appendix Table 1. Operationalization in the CIDI of criteria for DSM-IV eating disorders and related entities Criteria* Operationalization from CIDI

Knowledge and Practice of Complementary Medicine Amongst Public Primary Care Clinic Doctors in Kinta District, Perak

Qigong. Jo Robins RN, PhD, ANP-C, AHN-C, FAANP

Dr. Kashyap Patel Chief Medical Officer, Agape Healthcare President, SCOS Board member, community oncology alliance Chief of Staff, Springs

Use of Complementary and Alternative Therapies: A Pilot Survey

WHOLE HEALTH: CHANGE THE CONVERSATION

THE ROLE OF INTEGRATIVE HEALTH IN IBD CARE

University of Arizona Medical Center. Survivorship. Mary Reid, PhD February 1, 2018

Wellness: Thriving with Brain Cancer VERONICA PORCHE, PSYD Clinical Psychologist Department of Neurosurgery OUTSMARTING BRAIN TUMORS PATIENT

CHAPTER 1 INTRODUCTION. To date, the incidence of chronic illness is consistently increasing. Many

Whole Health for Pain and Suffering

Pain Management in Patients with Fibromyalgia

Complementary and Alternative Therapies

Alternative Medicine is the use of. Complementary Medicine refers to a ALTERNATIVE MEDICINES AND CANCER THERAPY** Alternative Medicine

SPRINGFIELD TECHNICAL COMMUNITY COLLEGE ACADEMIC AFFAIRS

Complementary and Alternative Medicine in the context of HIV disease and HAART

P HC. There is a growing interest in the use of complementary and alternative. The Use of. Complementary and. Alternative

Integrative Medicine and Being Your Healthiest Self Adding Mind-Body Medicine to your Holiday!

Beyond Cancer Moving On

Complementary therapies

USE OF ALTERNATIVE MEDICINE BY WOMEN WITH EARLY-STAGE BREAST CANCER. Special Article

The use of complementary and alternative medicine (CAM) in

Complementary Medicines and Therapies Criteria Based Access Protocol Supporting people in Dorset to lead healthier lives

Complementary & Alternative Medicine. Integrative Therapies:

Name (First, Middle initial, Last): Mailing Address: Home phone: Cell Gender identification: M F Birthdate: Age: Birthplace:

Primary Care Physicians Attitudes and Practices Regarding Complementary and Alternative Medicine

Complementary therapies. Helmut Roniger

Author Appendix Contents. Appendix A. Model fitting results for Autism and ADHD by 8 years old

A Patient s Guide to Pain Management: Body Talk

Choosing the Right Herbs for You

INITIAL YOGA THERAPY ASSESSMENT

Health Psychology. Symptoms and Mood. Symptom Perception & Reporting. Recognition and Interpretation of Symptoms: Recognition

An Introduction to Complementary and Alternative Medicine (CAM) 2008

ORIGINAL INVESTIGATION. Results of a National Survey on Prevalence and Patterns of Use

Complementary and Alternative Therapies

Integrative Medicine (Formerly known as CAM)

Patient-Friendly IM Resources

The Role of Naturopathic and Chinese Medicines in Supportive Care of Cancer Patients

C.A.M. Use of HIV/AIDS Patients in the Largest Mexican American Border Region

Complementary Therapies in Cancer Care

Complementary & Integrative Medicine for Headaches

Complementary and Alternative Health Approaches: What Really Works?

Oxford Cambridge and RSA

Frequency of Use of Complementary and Alternative Medicine in Women with Breast Cancer

Nonpharmacologic pain management

Appendix Table 1. Operationalization in the CIDI of criteria for DSM-IV eating disorders and related entities Criteria* Operationalization from CIDI

Complementary and Alternative Medicine: Current Mind-Body Practices and Perceptions of Undergraduate Students

Wellness along the Cancer Journey: American Indian, Alaska Native, and Complementary Healing

Healing Children's Attention & Behavior Disorders: Complementary Nuttritional & Psychological Treatments (Professional Edition) By Dr.

Article. The Use of Complementary and Alternative Therapies to Treat Anxiety and Depression in the United States

Mind-Body Medicine: Enriching Well-being

Support for Kidney Cancer

Hungry Mice. NP: Mice in this group ate as much as they pleased of a non-purified, standard diet for laboratory mice.

4/25/2017. Pain Management. Who I Am. What I ll Cover Today

Herbal Product Education in United States Pharmacy Schools: Core or Elective Program?

Flexi Extras. Your guide to. Questions? Need Advice? Our consultants are available to help.

Care of the Patient with Cancer

Integrative and Holistic Health and Healthcare

arah s CLIENT INFORMATION M A S S A G E T H E R A P Y

HealthPartners Inspire Special Needs Basic Care Clinical Care Planning and Resource Guide CHRONIC PAIN

What are Alternative Pain Methods

Today a growing number of physicians are interested

INTEGRATIVE ONCOLOGY

THE USE OF DIETARY SUPPLEMENTS AMONG INDIVIDUALS ENROLLED IN CLINICAL TRIALS FOR THE TREATMENT OF CANCER. Linda Barry Robertson

Care Management Care Review Collaborative. February 16, 2018 Guest Specialist Dave Williams PHD

Chapter 17 2/19/2015. Complementary and Alternative Therapies. Complementary and Alternative Therapies. Complementary and Alternative Therapies cont d

Pediatric Primary Care Mental Health Specialist Certification Exam. Detailed Content Outline

Sunil Nagpal MD Director, Thoracic Oncology West Michigan Cancer Center

ICD-10 and DSM-5: Making Sense in the Clinical Environment. Mehul Mankad, MD Assistant Professor Duke University Medical Center

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Personality Disorder: the clinical management of borderline personality disorder

Screening & Assessment for Trauma in Drug Courts

Read & Download (PDF Kindle) Complementary And Alternative Medicine: Legal Boundaries And Regulatory Perspectives

Promoting and protecting mental Health. Supporting policy trough integration of research, current approaches and practice

Richard L Nahin 1*, Danita Byrd-Clark 2, Barbara J Stussman 1 and Nilesh Kalyanaraman 1

Chronic Pain Management Strategies

Complementar y and Alternative Therapies

Clinical Assessment. Client Name (Last, First, MI) ID # Medicaid # DOB: Age:

Index. Note: Page numbers of article titles are in boldface type.

Sleep, Stress, and Fatigue

Transcription:

Appendix Table 1. Distribution of treatment across sub-samples defining a gradient of need for treatment across service sectors 1 Other mental Sub-sample % (se) % (se) % (se) % (se) % (se) Any 12-month DSM-IV/CIDI disorder 70.2 (2.3) 67.4 (1.9) 65.7 (2.3) 62.8 (3.9) 64.3 (3.6) Lifetime but not 12-month diagnosis 16.0 (2.1) 20.5 (2.0) 18.8 (1.6) 19.9 (2.6) 24.4 (3.2) One or more other indicator of potential need, * no lifetime or 12-month 10.2 (2.1) 8.4 (1.7) 8.5 (1.2) 9.1 (3.4) 4.9 (1.6) diagnosis No diagnosis or other indicator of potential need 3.6 (1.2) 3.7 (1.4) 7.0 (1.4) 8.2 (3.3) 6.5 (2.6) Total sample 100 100 100 100 100 1 Percentages are based on the weighted numbers of respondents in treatment in each sub-sample *Subthreshold syndrome, lifetime hospitalization, or 12-month serious stressor

Appendix Table 2. Mean number of visits across sub-samples defining a gradient of need for treatment across service sectors 1 Sub-sample mean (se) mean (se) mean (se) mean (se) mean (se) Any 12-month DSM-IV/CIDI disorder 7.8 (1.0) 17.8 (1.4) 2.9 (0.2) 6.9 (0.8) 28.1 (4.2) Lifetime but not 12-month diagnosis 7.9 (3.6) 14.0 (2.0) 1.9 (0.2) 5.8 (1.5) 33.9 (6.6) One or more other indicator of potential need, 5.6 (1.4) 10.5 (2.5) 2.7 (0.4) 3.2 (0.8) 24.3 (15.6) no lifetime or 12-month diagnosis * No diagnosis or other indicator of potential need* 3.9 (1.0) 10.3 (4.5) 1.4 (0.2) 16.5 (13.2) 34.8 (29.1) Total sample 7.5 (0.9) 16.1 (1.0) 2.6 (0.1) 7.1 (1.5) 29.8 (3.9) χ 2, df, p-value 2.7 396.058 3.4 518.026 13.4 768 <.0001 4.4 261.009 0.5 242.714 *Subthreshold syndrome, lifetime hospitalization, or 12-month serious stressor

Appendix Table 3. Distribution of visits across service sectors within subsamples defining a gradient of need for treatment (column percentages) 1 Other mental % (se) % (se) % (se) % (se) % (se) Any 12 Month MH Disorder 73.5 (6.1) 74.3 (2.7) 73.4 (2.3) 60.8 (10.0) 60.7 (5.9) Lifetime but not 12-month diagnosis 16.9 (6.4) 17.8 (2.7) 14.1 (1.4) 16.3 (5.0) 27.7 (4.6) One or more other indicator of potential need, no lifetime or 12-month 7.6 (1.7) 5.5 (1.7) 8.8 (1.9) 4.1 (1.6) 4.0 (0.7) diagnosis * No diagnosis or other indicator of potential need* 1.9 (0.8) 2.4 (1.2) 3.7 (0.8) 18.9 (13.3) 7.6 (6.3) Total 100.0 100.0 100.0 100.0 100.0 1 Percentages are based on the weighted numbers of respondents in treatment in each sub-sample *Subthreshold syndrome, lifetime hospitalization, or 12-month serious stressor

Appendix Table 4. Estimated level of need score components for persons with lifetime but not 12-month DSM-V/CIDI disorder Component name Component Weight Prevalence Prevalence % (se) 1 LTO Bipolar 2 3.1 (0.4) 2 <2 LT Disorder 0 69.8 (1.4) 3 2-4 LT Disorders 1 28.1 (1.3) 4 5+ LT Disorders 4 2.2 (0.3) 5 1 Year Recency 3 13.8 (0.9) 6 2-4 Yrs Recency 2 25.0 (1.4) 7 5-9 Yrs Recency 1 20.8 (1.2) 8 10+ Yrs Recency 0 40.4 (1.7) 9 Subthreshold 2 23.5 (1.2) 10 LT Hospitalization 3 11.6 (1.0) 11 Stressor this Year 3 18.5 (1.3)

Appendix Table 5. Percentages of persons who received treatment among respondents with a lifetime but not 12-month DSM-IV/CIDI disorder by estimated level of need and service sector Sub-sample % (se) % (se) % (se) % (se) % (se) 0 1.0 (0.5) 2.9 (1.1) 4.0 (1.5) 0.5 (0.3) 0.8 (0.5) 1-3 2.0 (0.6) 4.9 (1.0) 5.0 (1.0) 1.1 (0.4) 0.9 (0.3) 4-8 5.7 (0.9) 8.7 (1.5) 14.5 (2.0) 6.9 (1.2) 6.6 (1.3) 9-15 22.5 (5.2) 26.3 (5.6) 32.2 (5.8) 19.4 (4.5) 25.7 (7.6) F or χ 2, df, p-value 53.1 3.0 <.0001 51.3 3.0 <.0001 38.6 3.0 <.0001 66.1 3.0 <.0001 69.6 3.0 <.0001 *Scale is a weighted score including the following components: lifetime diagnosis of bipolar disorder; number of lifetime diagnoses; recency of diagnosis; lifetime hospitalization; subthreshold symptoms; serious 12-month stressor.

Appendix Table 6. Distribution of treatment among respondents with a lifetime but not 12-month DSM-IV/CIDI disorder by estimated level of need and service sector % (se) % (se) % (se) % (se) % (se) 0 5.7 (2.5) 9.2 (4.1) 9.3 (3.5) 2.9 (2.0) 4.6 (3.1) 1-3 27.0 (6.2) 36.5 (5.9) 27.5 (5.5) 15.9 (5.0) 13.0 (4.9) 4-8 50.1 (6.6) 42.9 (5.6) 53.1 (7.0) 65.3 (7.7) 61.6 (6.3) 9-15 17.2 (4.5) 11.3 (3.2) 10.2 (2.5) 16.0 (5.2) 20.8 (4.8) *Scale is a weighted score including the following components: lifetime diagnosis of bipolar disorder; number of lifetime diagnoses; recency of diagnosis; lifetime hospitalization; subthreshold symptoms; serious 12- month stressor.

Appendix Table 7. Mean number of visits among respondents with a lifetime but not 12-month DSM-IV/CIDI disorder by estimated level of need and service sector Sub-sample % (se) % (se) % (se) % (se) % (se) 0 2.0 (0.5) 6.6 (2.6) 1.6 (0.2) 2.0 (0.7) 27.0 (23.5) 1-3 3.1 (0.8) 14.0 (4.2) 1.6 (0.1) 2.5 (0.7) 30.6 (7.6) 4-8 5.1 (1.0) 10.1 (1.9) 2.2 (0.2) 5.5 (1.9) 19.9 (3.7) 9-15 25.8 (18.3) 35.1 (10.4) 2.0 (0.2) 11.0 (4.6) 78.6 (24.9) F or χ 2, df, p-value 3.4 65.0.025 3.1 95.0.037 3.1 142.0.038 2.3 53.0.094 2.4 56.0.081 *Scale is a weighted score including the following components: lifetime diagnosis of bipolar disorder; number of lifetime diagnoses; recency of diagnosis; lifetime hospitalization; subthreshold symptoms; serious 12-month stressor.

Appendix table 8. Distribution of visits among respondents with a lifetime but not 12-month DSM-IV/CIDI disorder by estimated level of need and service sector % (se) % (se) % (se) % (se) % (se) 1 0 1.4 (0.9) 4.4 (1.7) 7.4 (2.8) 1.0 (0.8) 3.7 (3.1) 2 1-3 10.5 (5.0) 36.5 (6.7) 22.8 (5.5) 6.7 (1.9) 11.8 (5.0) 3 4-8 32.1 (14.8) 30.8 (4.3) 59.5 (7.8) 62.0 (13.5) 36.2 (4.0) 4 9-15 55.9 (20.1) 28.3 (8.6) 10.2 (2.7) 30.3 (13.9) 48.4 (6.2) *Scale is a weighted score including the following components: lifetime diagnosis of bipolar disorder; number of lifetime diagnoses; recency of diagnosis; lifetime hospitalization; subthreshold symptoms; serious 12-month stressor.

Appendix Table 9. Estimated level of need score components for persons with Neither Lifetime nor 12-month DSM-IV/CIDI disorder Component Name Component weight Prevalence Prevalence % (se) 1 Subthreshold 1 14.4 1.2 2 LT Hospitalization 2 1.9 0.2 3 Stressor this Year 2 14.4 0.9

Appendix Table 10. Appendix Table 5. Distribution of treatment with neither lifetime nor 12-month DSM-IV/CIDI disorder by estimated level of need and service sector* % (se) % (se) % (se) % (se) % (se) 1 0 26.1 (8.3) 30.5 (10.7) 45.1 (6.5) 47.3 (15.3) 57.2 (12.9) 2 1 30.1 (9.0) 16.9 (6.4) 18.5 (4.0) 10.5 (8.3) 19.0 (12.1) 3 2 26.7 (9.7) 30.0 (8.8) 19.3 (7.2) 18.8 (10.5) 13.0 (6.5) 4 3-5 17.1 (6.9) 22.5 (8.4) 17.1 (3.4) 23.5 (12.9) 10.8 (5.2) *Scale is a weighted score including the following components: lifetime mental diagnosis, subthreshold symptoms; serious 12-month stressor.

Appendix Table 11. Mean number of visits for persons with neither lifetime nor 12-month DSM-IV/CIDI disorder by estimated level of need and service sector* Obs Avg (se) p Avg (se) p Avg (se) p Avg (se) p Avg (se) p 1 0 3.9 (1.0) 10.3 (4.5) 1.4 (0.2) 16.5 (13.2) 34.8 (29.1) 2 1 2.5 (0.3) 12.3 (2.8) 2.6 (0.7) 1.4 (0.4) 1.3 (0.3) 3 2 7.3 (3.1) 8.7 (3.7) 3.3 (0.5) 3.1 (0.6) 7.2 (3.0) 4 3-5 8.4 (1.1) 11.6 (5.6) 2.0 (0.4) 4.1 (1.6) 85.4 (37.3) 5 F or Chi/DF/p-value 8.7 (33.0).0001 0.2 (34.0).881 5.3 (75.0).004 3.2 (14.0).031 4.8 (13.0).006 *Scale is a weighted score including the following components: lifetime mental diagnosis, subthreshold symptoms; serious 12-month stressor.

Appendix table 12. Distribution of visits for persons with neither lifetime nor 12- month DSM-IV/CIDI disorder by estimated level of need and service sector* % (se) % (se) % (se) % (se) % (se) 1 0 19.8 (4.8) 30.2 (13.9) 29.4 (6.1) 82.3 (1.8) 65.6 (1.9) 2 1 14.9 (6.2) 20.0 (8.8) 23.1 (5.2) 1.5 (0.6) 0.8 (0.3) 3 2 37.6 (9.9) 24.9 (2.4) 30.8 (10.3) 6.1 (0.1) 3.1 (0.1) 4 3-5 27.8 (8.0) 24.9 (11.5) 16.7 (2.9) 10.1 (1.6) 30.5 (2.0) *Scale is a weighted score including the following components: lifetime mental diagnosis, subthreshold symptoms; serious 12-month stressor.

Appendix table 13. Use of complementary and alternative therapies among persons with and without 12-Month DSM-IV/CIDI disorders Obs catnum cat M12_Pct M12_SE LTO_Pct LTO_SE NEED_Pct NEED_SE OTHER_Pct OTHER_SE 1 14 ALTERNATIVE THERAPY USED? -- -- -- -- -- -- -- -- 2 15 Acupuncture 8.8 3.0 4.2 2.2 0.0 0.0 0.0 0.0 3 16 Biofeedback 6.3 2.8 2.7 2.1 0.0 0.0 0.0 0.0 4 17 Chiropractic 18.4 4.3 11.4 5.6 18.6 9.9 0.0 0.0 5 18 Energy Healing 13.8 4.5 3.2 1.8 0.0 0.0 0.0 0.0 6 19 Excercise or Movement Therapy 26.8 5.5 25.5 6.7 12.8 4.6 3.7 3.9 7 20 Herbal Therapy 22.6 4.8 14.0 4.6 0.0 0.0 0.0 0.0 8 21 High Dose Megavitamin 17.9 4.3 12.9 5.0 0.0 0.0 4.9 4.8 9 22 Homeopathy 8.7 3.5 2.8 2.0 5.6 6.0 0.0 0.0 10 23 Hypnosis 1.7 1.0 1.7 1.7 0.0 0.0 0.0 0.0 11 24 Imagery Techniques 7.3 2.1 8.5 2.9 0.0 0.0 0.0 0.0 12 25 Massage Therapy 21.6 4.5 16.9 5.9 0.0 0.0 0.0 0.0 13 26 Prayer/Spiritual Practices 53.4 3.1 39.8 6.5 66.5 13.1 44.8 19.9 14 27 Relaxation/Meditation 32.1 3.8 32.6 7.1 0.0 0.0 3.7 3.9 15 28 Special Diets 7.9 2.4 6.7 3.0 7.8 9.3 0.0 0.0 16 29 Spiritual Healing 14.9 3.3 8.3 4.3 7.8 9.3 0.0 0.0 17 30 Other Non-traditional 6.1 1.9 11.5 4.7 0.0 0.0 0.0 0.0 18 31 GROUP ATTENDED? -- -- -- -- -- -- -- -- 19 32 Substance Problems 21.6 3.6 38.7 6.4 34.9 19.5 0.0 0.0 20 33 Emotional Problems 11.5 2.8 4.7 2.4 7.2 7.5 0.0 0.0 21 34 Eating Disorders 1.1 0.9 3.0 2.5 0.0 0.0 0.0 0.0 22 35 Bereavement 4.2 1.5 0.0 0.0 12.4 10.2 0.0 0.0 23 36 Life Transition 2.7 1.3 0.0 0.0 0.0 0.0 0.0 0.0 24 37 Survivors 7.9 2.3 10.6 4.7 0.0 0.0 0.0 0.0 25 38 Own Disability or Illness 2.0 1.2 0.6 0.6 3.5 3.6 14.7 11.4 26 39 Parenting Support 1.2 0.7 0.0 0.0 9.0 8.7 0.0 0.0 27 40 Family Support w Physical Illness 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 28 41 Family Support w Mental Illness 10.6 2.7 3.9 2.9 9.0 8.7 0.0 0.0